These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23117089)

  • 21. Anti-aggregation effect of aroxyalkyl derivatives of 2-methoxyphenylpiperazine is due to their 5-HT
    Kubacka M; Kazek G; Kotańska M; Filipek B; Waszkielewicz AM; Mogilski S
    Eur J Pharmacol; 2018 Jan; 818():263-270. PubMed ID: 29111111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro study on the effects of some selected agonists and antagonists of alpha(1)-adrenergic receptors on the contractility of the aneurysmally-changed aortic smooth muscle in humans.
    Gnus J; Czerski A; Ferenc S; Zawadzki W; Witkiewicz W; Hauzer W; Rusiecka A; Bujok J
    J Physiol Pharmacol; 2012 Feb; 63(1):29-34. PubMed ID: 22460458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular design and synthesis of 1,4-disubstituted piperazines as α(1)-adrenergic receptor blockers.
    Abou El-Ella DA; Hussein MM; Serya RA; Abdel Naby RM; Al-Abd AM; Saleh DO; El-Eraky WI; Abouzid KA
    Bioorg Chem; 2014 Jun; 54():21-30. PubMed ID: 24727279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypotensive and antiaggregative effects of eugenosedin-B with serotonin and alpha/beta-adrenoceptor antagonistic activities in rats and human platelets.
    Shen KP; Chu LW; Hsieh SL; An LM; Chen IJ; Wu BN
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):154-61. PubMed ID: 18287883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential vascular α
    Álvarez-Cámara JF; Ramírez-Rosas MB; Medina-Terol GJ; Silva-Velasco DL; Velazco-Paz A; Sánchez-López A; Guzman-Priego CG; Osuna-Martínez U; Centurión D
    Eur J Pharmacol; 2019 Sep; 858():172498. PubMed ID: 31238063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic benefits of 1-(3-(4-(o-tolyl)piperazin-1-yl)propyl)pyrrolidin-2-one: a non-selective α-adrenoceptor antagonist.
    Kotańska M; Kulig K; Marcinkowska M; Bednarski M; Malawska K; Zaręba P
    J Endocrinol Invest; 2018 May; 41(5):609-619. PubMed ID: 29110282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arylsulfonamide derivatives of (aryloxy)ethyl pyrrolidines and piperidines as α
    Rak A; Canale V; Marciniec K; Żmudzki P; Kotańska M; Knutelska J; Siwek A; Stachowicz G; Bednarski M; Nowiński L; Zygmunt M; Zajdel P; Sapa J
    Bioorg Med Chem; 2016 Nov; 24(21):5582-5591. PubMed ID: 27658792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prazosin-related compounds. Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for alpha1-adrenoreceptors.
    Rosini M; Antonello A; Cavalli A; Bolognesi ML; Minarini A; Marucci G; Poggesi E; Leonardi A; Melchiorre C
    J Med Chem; 2003 Nov; 46(23):4895-903. PubMed ID: 14584940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
    Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
    Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and biological evaluation of new arylpiperazine derivatives bearing a flavone moiety as α1-adrenoceptor antagonists.
    Jin J; Wang XB; Kong LY
    Bioorg Med Chem Lett; 2011 Feb; 21(3):909-11. PubMed ID: 21236664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat.
    McDaid J; Docherty JR
    Br J Pharmacol; 2001 Jun; 133(3):429-37. PubMed ID: 11375260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of the in vivo and in vitro cardiovascular effects of four new analogues of ketanserin: implication of 5-HT2A and alpha1 adrenergic antagonism in their hypotensive effect.
    Orallo F; Tristan H; Garcia-Ferreiro T; De Francisco S; Masaguer C; Raviña E; Calleja JM; Cadavid I; Loza MI
    Biol Pharm Bull; 2000 May; 23(5):558-65. PubMed ID: 10823664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypotensive effects of eugenosedin-A with serotonin, alpha- and beta-adrenoceptor antagonistic activities in spontaneously hypertensive and normotensive rats.
    Shen KP; Chiu CC; Chen SJ; Chen IJ; Wu BN
    Pharmacology; 2004 Jun; 71(2):91-101. PubMed ID: 15118348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as α1A/1D-AR subselective antagonists for BPH.
    Xu F; Chen H; Xu J; Liang X; He X; Shao B; Sun X; Li B; Deng X; Yuan M
    Bioorg Med Chem; 2015 Dec; 23(24):7735-42. PubMed ID: 26643219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative alpha-1 adrenoceptor subtype selectivity and functional uroselectivity of alpha-1 adrenoceptor antagonists.
    Martin DJ; Lluel P; Guillot E; Coste A; Jammes D; Angel I
    J Pharmacol Exp Ther; 1997 Jul; 282(1):228-35. PubMed ID: 9223558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RBx 6198: a novel alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia.
    Nanda K; Naruganahalli KS; Gupta S; Malhotra S; Tiwari A; Hegde LG; Jain S; Sinha N; Gupta JB; Chugh A; Anand N; Ray A
    Eur J Pharmacol; 2009 Apr; 607(1-3):213-9. PubMed ID: 19239913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Subtype Selectivity in Search of Potent Hypotensive Agents among 5,5-Dimethylhydantoin Derived α
    Kaczor A; Knutelska J; Kucwaj-Brysz K; Zygmunt M; Żesławska E; Siwek A; Bednarski M; Podlewska S; Jastrzębska-Więsek M; Nitek W; Sapa J; Handzlik J
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional characterization of alpha 1-adrenoceptor subtypes in vascular tissues using different experimental approaches: a comparative study.
    Gisbert R; Madrero Y; Sabino V; Noguera MA; Ivorra MD; D'Ocon P
    Br J Pharmacol; 2003 Jan; 138(2):359-68. PubMed ID: 12540527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An investigation of the uroselective properties of four novel alpha(1a)-adrenergic receptor subtype-selective antagonists.
    Pulito VL; Li X; Varga SS; Mulcahy LS; Clark KS; Halbert SA; Reitz AB; Murray WV; Jolliffe LK
    J Pharmacol Exp Ther; 2000 Jul; 294(1):224-9. PubMed ID: 10871316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiarrhythmic and α-Adrenoceptor Antagonistic Properties of Novel Arylpiperazine Derivatives of Pyrrolidin-2-one.
    Zaręba P; Dudek M; Lustyk K; Siwek A; Starowicz G; Bednarski M; Nowiński L; Zygmunt M; Sapa J; Malawska B; Kulig K
    Arch Pharm (Weinheim); 2015 Dec; 348(12):861-7. PubMed ID: 26523954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.